Citigroup Investment Research & Analysis Analyst Garen Sarafian says displacement opportunities in the inpatient market will increasingly go to what he calls “winners.” He says that by definition, displacement opportunities mean customers are pulling out of one vendor, or an in-house system, and awarding the business to a new vendor. He says Cerner Corporation (CERN) will be a beneficiary of that dynamic.
“On the inpatient side among our coverage universe, Cerner is one that we like a lot, using that same framework of being successful in the EMR market as well as having the products available for the analytical portion of the needs and providers,” Sarafian says. “They are highly successful on both. In the EMR market, on the inpatient side, it’s essentially a two-horse race with a private competitor, and they have great references, are highly reputable.”
FOR MORE INFORMATION ON THIS INTERVIEW CLICK HERE.
Sarafian says the inpatient market is already conservative, and hesitant to engage vendors with whom they’ve had bad experiences in the past. He says Cerner’s reputation should help the company win new business.
“If they didn’t like a vendor before, they are going to go with whoever is giving the best reference points and the EMR that’s the least amount of risk to them,” Sarafian says. “In the inpatient market that will favor Cerner because again, it’s become a two-company horse race and they are the public company there.”
Lower Profitability in Health Care Market Creates Demand for Cerner Corporation’s (CERN) Services
May 12, 2015
Cerner Corporation (CERN) Steps Ahead of Demand Curve with Population Health Management Efforts
October 25, 2013
Catamaran (CTRX), Cerner (CERN) and athenahealth (ATHN) Enable HITECH Act Meaningful Use Adoption of EHR
October 24, 2012
Rowan Companies PLC (RDC) to Benefit as Jackup Market Outperforms Floating Rig Market
February 07, 2014
8×8, Inc. (EGHT) to Benefit from Continued Growth of VoIP in the U.S.; Eyes International Opportunities
July 23, 2013
